Page 207 - Cellular Imaging in Regenerative Medicine, Cancer and Osteoarthritis

for long term cell tracking on MSC differentiation in vitro and in vivo. Biochem Biophys Res Commun. 2008 May 16;369(4):1076-81
Seynhaeve AL, Hoving S, Schipper D, Vermeulen CE, de Wiel-Ambagtsheer G, van Tiel ST, Eggermont AM, Ten Hagen TL. Tumor necrosis factor alpha mediates homogeneous distribution of liposomes in murine melanoma that contributes to a better tumor response. Cancer Res. 2007 Oct 1;67(19):9455-62.
Brunstein F, Rens J, van Tiel ST, Eggermont AM, ten Hagen TL. Histamine, a vasoactive agent with vascular disrupting potential, improves tumour response by enhancing local drug delivery. Br J Cancer. 2006 Dec 18;95(12):1663-9
Brunstein F, Eggermont AM, de Wiel-Ambagtsheer G, van Tiel ST, Rens J, ten Hagen TL. Synergistic antitumor effects of histamine plus melphalan in isolated hepatic perfusion for liver metastases. Ann Surg Oncol. 2007 Feb;14(2):795-801
Hoving S, Seynhaeve AL, van Tiel ST, aan de Wiel-Ambagtsheer G, de Bruijn EA, Eggermont AM, ten Hagen TL. Early destruction of tumor vasculature in tumor necrosis factor-alpha-based isolated limb perfusion is responsible for tumor response. Anticancer Drugs. 2006 Sep;17(8):949-59.
Brunstein F, Santos ID, Ferreira LM, van Tiel ST, Eggermont AM, Ten Hagen TL. Histamine combined with melphalan in isolated limb perfusion for the treatment of locally advanced soft tissue sarcomas: preclinical studies in rats. Acta Cir Bras. 2005 Jul-Aug;20(4):275-9
Hoving S, Seynhaeve AL, van Tiel ST, Eggermont AM, ten Hagen TL. Addition of low-dose tumor necrosis factor-alpha to systemic treatment with STEALTH liposomal doxorubicin (Doxil) improved anti-tumor activity in osteosarcoma- bearing rats. Anticancer Drugs. 2005 Jul;16(6):667-74.
Hoving S, Brunstein F, Aan de Wiel-Ambagtsheer G, van Tiel ST, de Boeck G, de Bruijn EA, Eggermont AM, Ten Hagen TL. Synergistic antitumor response of interleukin 2 with melphalan in isolated limb perfusion in soft tissue sarcoma- bearing rats. Cancer Res. 2005 May 15; 65(10):4300-8.
PhD Portfolio
205
11